Further twists in heparin scandal
A member of the US Congress has called on the GAO to launch an investigation into the FDA’s handling of the heparin crisis, citing “unanswered questions concerning [the] deaths”.
AZ to slash more European jobs and ramp-up China investment
AstraZeneca is to cut 1,400 jobs and close more manufacturing facilities by 2013, as it attempts to slim down in preparation for impending generic competition for some of its cornerstone drugs.
Asia to drive glycerin market out to 2015
Demand for glycerin as an ingredient in pharmaceuticals, personal care and other products is expected to show brisk growth out 2015, when demand around the world is expected to reach 3.39 billion pounds, according to market research firm Global Industry...
Taiwan’s biotech statute continues to attract global players
Taiwan’s efforts to position itself as a major biotechnology hub received a further boost today with the opening of Merck KGaA’s dedicated technology training centre in Xizhi City, Taipei County.
NAFDAC blacklists 22 drug fakers
The NAFDAC has banned 22 firms that it says are involved in the manufacture of fake drugs from ever again selling pharmaceuticals in Nigeria, as part of a countrywide clampdown.
Wyeth to cut jobs at Irish subsidiary
Wyeth Medica, an Irish subsidiary of US drugmaker Wyeth, plans to cut 250 jobs at its manufacturing plant in Newbridge, County Kildare, according to media reports.
Certification at top of agenda for IPEC Europe
The International Pharmaceutical Excipients Council (IPEC) of Europe has outlined the actions it is taking as it continues to develop awareness of the need for safe excipients.
IPEC China’s chairman sets out next steps
Exclusive interview with IPEC China chairman Nevin Cheng
IPEC China must become a “harmonisation bridge between China and other countries,” according to Colorcon’s Nevin Cheng who was recently elected chairman of the new organisation.
USP opens its first site in Brazil
The US Pharmacopeia (USP) has continued to expand its global reach by opening a site in São Paulo, Brazil; its first in Latin America.
Excipients supply chain still needs tightening
Although there has been considerable industry effort to monitor and
control the distribution of pharmaceutical raw materials, the
voluntary nature of this regulation means that the supply network
is still susceptible to unscrupulous...
Pharma must adapt to emerging markets
Pharmaceutical companies are having to radically change their
practices when it comes to tackling emerging markets such as China,
India, Russia and Brazil, according to IMS.
China set to become fourth IPEC region
China is on course to having its own version of the International
Pharmaceutical Excipients Council - joining its fellow
organisations in Europe, the Americas and Japan.
Legislation proposed for FDA foreign inspections
Draft legislation has been put forward which would require the US
Food and Drug Administration (FDA) to inspect foreign manufacturing
plants every four years.
FDA suspects heparin contamination due to fraud
The US Food and Drug Administration (FDA) believes that the
contamination of Baxter's blood thinner heparin, which has been
linked to 62 deaths in the US, may have been due to the deliberate
replacement of some ingredients with...
US and Chinese pharmacopoeias expand working relationship
The pharmacopoeias of the US and China will work more closely
together in future in a bid to improve the quality of medicines
available in both countries.